Our attention was caught by the relatively poorly investigated NRP1 ligand Galectin-1 (Gal-1), encoded by the gene LGALS1 [14,17], which has been associated with cancer progression in numerous studies and is also considered a potential therapeutic target [18,19]. Here, NRP1 is linked to cancer.